Explore

Search ClinicalTrials.gov

Find trials by condition, intervention, sponsor, or location. Filter by status, phase, and study type — or enter an NCT ID to jump straight to a trial.

Find trials by country, state, or city

Search by locations

RecruitingPhase IIIPhase III recruiting

StatusPhaseStudy typeSort

Results for “Japan”

A Study to Evaluate the Long-term Safety, Tolerability and Efficacy of Bimekizumab in Subjects With Active Axial Spondyloarthritis Including Ankylosing Spondylitis and Nonradiographic Axial SpondyloarthritisCompleted
NCT04436640Phase 3Updated Sep 10, 2026
Sponsor: UCB Biopharma SRL
Axial Spondyloarthritis · Ankylosing Spondylitis · r-axSpa · Nr-axSpa
United States, Belgium, Bulgaria, China, Czechia +9 more
A Study to Evaluate the Safety and Efficacy of MK-3120 in Participants With Advanced Solid Tumors (MK-3120-002)Recruiting
NCT06818643Phase 1, Phase 2Updated Sep 10, 2026
Sponsor: Merck Sharp & Dohme LLC
Advanced Solid Tumors · Malignant Neoplasm
United States, Chile, China, France, Israel +7 more
Fasenra Pediatric Japan Post-Marketing Study(PMS)Active Not Recruiting
NCT06427876N/AUpdated Sep 10, 2026
Sponsor: AstraZeneca
Bronchial Asthma
Japan
A Late Phase II Clinical Trial of KDT-3594 in Patients With Parkinson's DiseaseCompleted
NCT06722729Phase 2Updated Sep 10, 2026
Sponsor: Kissei Pharmaceutical Co., Ltd.
Parkinson Disease
Japan
Specified Drug-use Surveillance of Fabhalta CapsulesActive Not Recruiting
NCT06606314N/AUpdated Sep 10, 2026
Sponsor: Novartis Pharmaceuticals
Paroxysmal Nocturnal Hemoglobinuria
Japan
Prevention of Recurrent C. Difficile Infection Study With AZD5148 Monoclonal AntibodyRecruiting
NCT07285213Phase 2Updated Sep 10, 2026
Sponsor: AstraZeneca
Clostridioides Difficile Infection
United States, Australia, Canada, Denmark, France +9 more
A Phase 2 Bridging Study of Elacestrant Monotherapy in Advanced or Metastatic Breast CancerRecruiting
NCT07766018Phase 2Updated Sep 10, 2026
Sponsor: Stemline Therapeutics, Inc.
Breast Cancer
Japan
Surgery With or Without Neoadjuvant Chemotherapy in High Risk RetroPeritoneal SarcomaRecruiting
NCT04031677Phase 3Updated Sep 10, 2026
Sponsor: European Organisation for Research and Treatment of Cancer - EORTC
Retroperitoneal Sarcoma · Liposarcoma · Leiomyosarcoma
United States, Australia, Canada, Cyprus, Czechia +10 more
A Study of Adjuvant Pembrolizumab/Vibostolimab (MK-7684A) Versus Pembrolizumab for Resected High-Risk Melanoma in Participants With High-Risk Stage II-IV Melanoma (MK-7684A-010/KEYVIBE-010)Terminated
NCT05665595Phase 3Updated Sep 10, 2026
Sponsor: Merck Sharp & Dohme LLC
Melanoma
United States, Argentina, Australia, Austria, Belgium +21 more
Long-Term Study That Measures the Safety and Efficacy of Deucravacitinib (BMS-986165) in Participants With PsoriasisCompleted
NCT04036435Phase 3Updated Sep 10, 2026
Sponsor: Bristol-Myers Squibb
Psoriasis
United States, Australia, Canada, China, Czechia +15 more
Placebo-controlled, Study of Concurrent Chemoradiation Therapy With Pembrolizumab Followed by Pembrolizumab and Olaparib in Newly Diagnosed Treatment-Naïve Limited-Stage Small Cell Lung Cancer (LS-SCLC) (MK 7339-013/KEYLYNK-013)Active Not Recruiting
NCT04624204Phase 3Updated Sep 10, 2026
Sponsor: Merck Sharp & Dohme LLC
Small Cell Lung Cancer
United States, Australia, Belgium, Bulgaria, Canada +20 more
A Study to Evaluate Effect of AZD6234 as an Adjunct to Incretin-based Therapies in Adult Participants With Obesity or Overweight With Weight-related Comorbidity With or Without Type 2 Diabetes MellitusRecruiting
NCT07776509Phase 3Updated Sep 10, 2026
Sponsor: AstraZeneca
Obesity or Overweight · Weight-Related Comorbidity · With/Without Diabetes Mellitus, Type 2
United States, Argentina, Brazil, Canada, China +6 more
Substudy 06E: Umbrella Study of Combination Therapies in Esophageal Cancer (MK-3475-06E/KEYMAKER-U06)Recruiting
NCT06780111Phase 1, Phase 2Updated Sep 10, 2026
Sponsor: Merck Sharp & Dohme LLC
Esophageal Squamous Cell Carcinoma
United States, Brazil, Chile, China, Czechia +11 more
A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With Heart Failure and InflammationTerminated
NCT05636176Phase 3Updated Sep 10, 2026
Sponsor: Novo Nordisk A/S
Heart Failure
United States, Argentina, Australia, Austria, Belgium +41 more
Study of Pelabresib add-on to Ruxolitinib in Japanese Adult Patients With MyelofibrosisActive Not Recruiting
NCT07340138Phase 1Updated Sep 9, 2026
Sponsor: Novartis Pharmaceuticals
Primary Myelofibrosis (PMF) · Post-polycythemia Vera Myelofibrosis (Post-PV MF) · Post-essential Thrombocythemia Myelofibrosis (Post-ET MF)
Japan
A Safety Study of SEA-CD70 in Patients With Myeloid MalignanciesActive Not Recruiting
NCT04227847Phase 1Updated Sep 9, 2026
Sponsor: Seagen, a wholly owned subsidiary of Pfizer
Myelodysplastic Syndrome · Acute Myeloid Leukemia
United States, Japan, Netherlands
A Master Protocol to Investigate Efficacy and Safety of Elecoglipron in Participants With Obesity or Overweight With or Without T2DMRecruiting
NCT07667803Phase 3Updated Sep 9, 2026
Sponsor: AstraZeneca
Weight Management
United States, Argentina, Australia, Brazil, Canada +14 more
Rollover Study for Participants Who Have Been Treated With and Are Continuing to Benefit From Opnurasib as a Single Agent or in Combination With Other Study TreatmentsRecruiting
NCT07468071Phase 1, Phase 2Updated Sep 9, 2026
Sponsor: Novartis Pharmaceuticals
Locally Advanced or Metastatic KRAS G12C-mutated Non-small Cell Lung Cancer · Advanced Solid Tumors Harboring the KRAS G12C Mutation
Belgium, Canada, China, Denmark, France +5 more
Trial of the Safety and Efficacy of Epcoritamab in Japanese Subjects With Relapsed or Refractory (R/R) B-Cell Non-Hodgkin Lymphoma (R/R B-NHL)Active Not Recruiting
NCT04542824Phase 1, Phase 2Updated Sep 9, 2026
Sponsor: Genmab
Diffuse Large B Cell Lymphoma · High-grade B-cell Lymphoma · Primary Mediastinal Large B Cell Lymphoma · Follicular Lymphoma
Japan
Assessment of Efficacy and Safety of Monalizumab Plus Cetuximab Compared to Placebo Plus Cetuximab in Recurrent or Metastatic Head and Neck CancerActive Not Recruiting
NCT04590963Phase 3Updated Sep 9, 2026
Sponsor: AstraZeneca
Squamous Cell Carcinoma of the Head and Neck
United States, Argentina, Australia, Austria, Belgium +18 more
Study to Assess the Efficacy, Pharmacokinetics, Safety and Tolerability of Iptacopan in Pediatric Patients With Primary IgANRecruiting
NCT06994845Phase 3Updated Sep 9, 2026
Sponsor: Novartis Pharmaceuticals
Primary Immunoglobulin A Nephropathy (IgAN)
United States, Argentina, Australia, China, Hong Kong +3 more
A Study of [68Ga]Ga-DWJ155 in Adult Patients With Solid TumorsRecruiting
NCT07801508Phase 1Updated Sep 9, 2026
Sponsor: Novartis Pharmaceuticals
Advanced Gastroesophageal Adenocarcinoma · Advanced Breast Cancer · Triple-negative Breast Cancer · Advanced Non-small Cell Lung Cancer
Japan
A Long-Term Study of Zasocitinib in Children and Teenagers With Plaque PsoriasisRecruiting
NCT07250802Phase 3Updated Sep 9, 2026
Sponsor: Takeda
Plaque Psoriasis
United States, China, Germany, Italy, Japan +2 more
OverTTuRe: Characteristics, Treatment Patterns and Outcomes of Patients With ATTR AmyloidosisRecruiting
NCT06355934N/AUpdated Sep 9, 2026
Sponsor: AstraZeneca
ATTR Amyloidosis
United States, Canada, China, Denmark, Germany +6 more
A Study to Investigate Efficacy and Safety of Teplizumab Compared With Placebo in Participants 1 to 25 Years of Age With Stage 3 Type 1 DiabetesRecruiting
NCT07088068Phase 3Updated Sep 9, 2026
Sponsor: Sanofi
Type 1 Diabetes Mellitus
United States, Argentina, Australia, Belgium, Brazil +12 more

Previous page Next page